The American Journal of Psychiatry

Official Journal of the American Psychiatric Association

  • 2014

ISBN
Item #AJP

Select Subscription Type
ADD TO CART

Watch the new AJP Video Series.

3 of Journal Watch Psychiatry’s 10 “Top Stories of 2014” appeared in The American Journal of Psychiatry.

The American Journal of Psychiatry’s latest Impact Factor is 12.295
according to the recently released 2014 Journal Citation Reports® (Thomson Reuters, 2015).

The American Journal of Psychiatry Named One of the Top 100 Most Influential
Journals in Biology and Medicine
over the last 100 Years by the Special Libraries Association.

The rates above apply to subscriptions starting in 2015. Renewal rates for 2016 subscriptions will be reflected at checkout when applicable.

  • Description

    Committed to keeping the field of psychiatry vibrant and relevant by publishing the latest advances in the diagnosis and treatment of mental illness, The American Journal of Psychiatry (AJP) is the most widely read psychiatric journal in the world and is the journal that the overwhelming majority of psychiatrists considers essential. Published monthly, it is an indispensable journal for all psychiatrists and other mental health professionals who need to stay on the cutting edge of virtually every aspect of psychiatry.

    AJP's latest Impact Factor is 13.559 according to the recently released 2013 Journal Citation Reports® (Thomson Reuters, 2014), placing it in the top 1% of all scientific, medical, and technical journals.

    AJP is number two in psychiatry in terms of immediacy according to Thomson Scientific’s Immediacy Index. This important performance metric is a good measure of how quickly a given journal’s articles are cited—AJP’s placement is a result of publishing articles that are relevant, covering current “hot” topics and cutting-edge research, and getting these findings to the field faster with AJP in Advance, the Journal’s online-ahead-of-print publication protocol.

    The findings presented in AJP explore the full spectrum of issues related to mental health diagnoses and treatment, with editorials that place the most groundbreaking research into clinical context.

    The editors of NEJM Journal Watch Psychiatry announced the 10 top psychiatry stories in 2014, and three were based on articles published in AJP.

    While publishing research at the forefront of the field, AJP contains in its back issues the foundation of psychiatry. A recent poll conducted by the BioMedical & Life Sciences Division of The Special Libraries Association identified the 100 most influential journals in all of Biology & Medicine over the last 100 years. AJP was among those honored, the only psychiatry/psychology journal represented.

    To visit the American Journal of Psychiatry online, please visit http://ajp.psychiatryonline.org

  • Contents

    Highlights from the January issue of American Journal of Psychiatry:

    The January issue of The American Journal of Psychiatry includes a discussion of hypercalcemia and hyperparathyroidism during lithium therapy. Two randomized clinical trials involved electroconvulsive therapy: in one it was used for treatment-resistant bipolar depression, and in the other the patients had clozapine-resistant schizophrenia. The issue also includes articles about a weight loss intervention tailored to individuals taking antipsychotic medications and an intervention for families of kindergartners with chronic conduct problems that was designed to improve outcomes at age 25. Socioeconomic disadvantage was the focus of a clinical trial that offered depression care in OB-GYN clinics and examined whether greater treatment response was related to type of insurance.

  • Customer Reviews
    Write a review

     
  • Editorial Reviews

  • Contributors

    Editorial Board

    Editor-in-Chief
    Robert Freedman, M.D.

    Deputy Editors
    David A. Lewis, M.D.
    Robert Michels, M.D.
    Daniel S. Pine, M.D.
    Susan K. Schultz, M.D.
    Carol A. Tamminga, M.D.

    Associate Editors
    Kathleen T. Brady, M.D., Ph.D.
    David A. Brent, M.D.
    Linda Brzustowicz, M.D.
    Cameron S. Carter, M.D.
    Howard H. Goldman, M.D., Ph.D.
    Daniel C. Javitt, M.D.
    Bankole Johnson, M.D.
    Ellen Leibenluft, M.D.
    Jeffrey A. Lieberman, M.D.
    Barbara Milrod, M.D.
    Maria A. Oquendo, M.D.
    Jerrold F. Rosenbaum, M.D.
    A. John Rush, M.D.
    Larry J. Siever, M.D.
    Patricia Suppes, M.D., Ph.D.
    Myrna M. Weissman, Ph.D.

    Editor Emeritus
    Nancy C. Andreasen, M.D., Ph.D.

    Former Editors
    Amariah Brigham, M.D., 1844–1849
    T. Romeyn Beck, M.D., 1849–1854
    John P. Gray, M.D., 1854–1886
    G. Alder Blumer, M.D., 1886–1894
    Richard Dewey, M.D., 1894–1897
    Henry M. Hurd, M.D., 1897–1904
    Edward N. Brush, M.D., 1904–1931
    Clarence B. Farrar, M.D., 1931–1965
    Francis J. Braceland, M.D., 1965–1978
    John C. Nemiah, M.D., 1978–1993

  • About the Author

    Robert Freedman, M.D., is Professor and Chair of Psychiatry at the University of Colorado. He is a graduate of Harvard Medical School and a member of the Institute of Medicine of the National Academies of Science. He was recently confirmed for membership into the Dana Alliance for Brain Initiatives, a nonprofit organization whose members are among the world's foremost authorities on neuroscientific research and clinical neurology topics.

You May Also Like...

  • Study Guide to Substance Abuse Treatment

    Study Guide to Substance Abuse Treatment

  • Psychiatric News

    Psychiatric News

  • FOCUS Psychiatry Review

    FOCUS Psychiatry Review